Dopamine preserves renal function: Present state of knowledge and appraisal of a controversial issue;Niedrig dosiertes dopamin verbessert die nierenfunktion: Derzeitiger kenntnisstand und bewertung einer kontroversen diskussion

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 32, Issue 6, 1997, Pages 333-342

  Kindgen Milles, D ^a   Tarnow, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acute renal failure; Dopamine; Renal function; Urine output

Indexed keywords

CREATININE; DIURETIC AGENT; DOPAMINE; SODIUM ION;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOPAMINE RELEASE; DOUBLE BLIND PROCEDURE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; URINE VOLUME; VASODILATATION;

EID: 0030820763     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995065     Document Type: Review

References (86)

1. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery, Ann. Intern. Med. 1994;120:744-747
2. Ball SG, Gunn IG, Douglas IHS: Renal handling of dopa, dopamine, norepinephrine, and epinephrine in the dog. Am. J. Physiol. 1982;242:F56-62
3. Bennett WM, Pulliam JP: Cyclosporine nephrotoxicity. Ann. Intern. Med. 1983;99:851-854
4. Bersten AD, Rutten AJ: Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis. Crit. Care Med. 1995;23: 537-544
5. Besses GS, Burrow GN, Spaulding SW, Donabedian RK: Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J. Clin. Endocrinol. Metab. 1975;41:985-987
6. Brivet FG, Kleinknecht DJ, Loirat P, Landais JM: Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter trial. Crit. Care Med. 1996;24:192-198
7. Cameron JS: Acute renal failure in the intensive care unit today. Intensive Care Med. 1986;12:64-70
8. Canadian Multicenter Transplant Study Group: A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N. Engl. J. Med. 1986;314:1219-1225
9. Carmellini M, Romagnoli J, Giulianotti PC, Pietrabissa A, di Stefano R, Rindi P, Rizzo G, Mosca F: Dopamine lowers the incidence of delayed graft function in transplanted kidney patients treated with cyclosporine A. Transplant. Proc. 1994;26: 2626-2629
10. Chiolero R, Borgeat A, Fisher A: Postoperative arrhythmias and risk factors after open-heart surgery. J. Thorac. Cardiovasc. Surg. 1991;39:81-84
11. Conger JD: Interventions in clinical acute renal failure: what are the data? Am. J. Kidney Dis. 1995;26:565-576
12. Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G: Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J. Cardiothorac. Anesth. 1990;4:469-473
13. Cottee DBF: Dopamine preserves renal function during cardiac surgery. Con: dopamine does not preserve renal function. J. Cardiothor. Vasc. Anesth. 1995;9:335-337
14. Cuche JL, Marchand GR, Greger RF, Lang FC, Knox FG: Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation. J. Clin. Invest. 1976;58:71-76
15. Davis RF, Lappas DG, Kirklin JK, Buckley MJ, Lowenstein E: Acute oliguria after cardiopulmonary bypass: renal functional improvement with low dose dopamine infusion. Crit. Care Med. 1982;10:852-856
16. 2-Verbrauchs der Niere von der Natriumrückresorption. Pflügers Archiv Ges. Physiol. 1961;273:636-670
17. de Lassen L, Hansen HE, Juhl B, Paaske WP, Pedersen EB: A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery. Eur. J. Endovasc. Surg. 1995;10:82-90
18. Denton MD, Chertow GM, Brady HR: "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 1996;49:4-14
19. Devins SS, Miller A, Herndon BL: Effects of dopamine on T-cell proliferative responses and serum prolactine concentrations in critically ill patients. Crit. Care Med. 1992;20:1644-1649
20. de Zegher F, van den Berghe G, Dumoulin M, Gewellig M, Daenen W, Devlieger H: Dopamine suppresses thyroid-stimulating hormone secretion in neonatal hypothyroidism. Acta Paediatr. 1995;84:213-214
21. Duke GJ, Bersten AD: Dopamine and renal salvage in the critically ill patient. Anaesth. Intens. Care 1992;20:277-287
22. Duke GJ, Briedis JH, Weaver RA: Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit. Care Med. 1994;22:1919-1925
23. Felder CC, McKelvey AM, Gitler MS, Eisner GM. Jose PA: Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int. 1989;36:183-193
24. Flancbaum L, Choban PS, Dasta JF: Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit. Care Med. 1994;22:61-66
25. Gabel JC: Dopamine: do the risks outweigh the benefits? In: Lawin P, Peter K, Prien T (Hrsg.): Intensivmedizin 1995 - Praxis der Intensivbehandlung. Thieme, Stuttgart 1995
26. Giraud GD, MacCannell KL: Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J. Pharmacol. Exp. Ther. 1984;230:214-230
27. Goldberg LI: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol. Rev. 1972;24:1-27
28. Graziani G, Cantaluppi A, Casati S, Citterio A, Scalamonga A, Aroldi A, Silenzio R, Brancaccio D, Ponticelli C: Dopamine and frusemide in oliguric renal failure. Nephron 1984;37:39-42
29. Greene SI, Smith JW: Dopamine gangrene. N. Engl. J. Med. 1976;294:114
30. Grundmann R, Kindler J, Meider G, Stowe G, Sieberth HG, Pichlmaier H: Dopamine treatment of human cadaver kidney graft recipients: a prospective randomized trial. Klin. Wschr. 1982;60:193-197
31. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, Bull DA, McIntyre KE, Bernhard VM, Misiorowski RL: Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J. Surg. Res. 1992;53:317-320
32. Harth O: Nierenfunktion. In: Schmidt RF, Thews G (Hrsg.): Physiologie des Menschen. Springer, Berlin, 1983
33. Heinrichs W: Positiver endexspiratorischer Druck (PEEP). Anaesthesist 1992;41:653-669
34. Henderson IS, Beattie TJ, Kennedy AC: Dopamine hydrochloride in oliguric states. Lancet 1980;2:827-828
35. Hilberman M, Maseda J, Stinson EB, Derby GC, Spender RJ, Miller DC, Oyer PE, Myers BD: The diuretic properties of dopamine in patients after open-heart surgery. Anesthesiology 1984;61: 489-494
36. Hines R: Dopamine preserves renal function during cardiac surgery. Pro: Dopamine and renal preservation. J. Cardiothor. Vase. Anesth. 1995;9:333-334
37. Hinshaw LB: Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit. Care Med. 1996;1072-1078
38. Huo T, Healy DP: Autoradiographic localisation of dopamine DA1 receptors in rat kidney with H3-SCH 23390. Am. J. Physiol. 1989; 257:F414-423
39. Jardin F, Gurdijan F, Desfonds P: Effect of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit. Care Med. 1979;7: 273-277
40. Jörgensen KA, Rohr N, Elbirk A, Svendsen V, Birkeland SA: Minnesota-ALG, forced diuresis, careful control of hydration, viral infection prophylaxis, and dopamine infusion in human renal transplantation. Transpl. Proc. 1992;24:358-359
41. Kebabian JW, Calne DB: Multiple receptors for dopamine. Nature 1979;277:93-96
42. Kramer K, Deetjen P, Brechtelsberger H: Gegenstromdiffusion des Sauerstoffs im Nierenmark. Pflügers Archiv Ges. Physiol. 1961;274:63-71
43. Leblanc H, Lachelin GCL, Abu-Fadil S, Yen SSC: Effects of dopamine on pituitary hormone secretions in humans. J. Clin. Endocrinol. Metab. 1976;43:668-674
44. Lindner A: Synergism of dopamine and furosemide in diureticresistant, oliguric acute renal failure. Nephron 1983;33:121-126
45. Lumergutl D, Keoplung M, Sitprija V, Moollaor P, Suwangool P: Furosemide and dopamine in malaria acute renal failure. Nephron 1989;52:40-44
46. Marik PE, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. J. Amer. Med. Assoc. 1994;272:1354-1357
47. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC: Increasing splanchnic blood flow in the critically ill. Chest 1995;108:1648-1654
48. Mousdale S, Clyburn PA, Mackie AM, Groves ND, Rosen M: Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers. Br. J. Clin. Pharmac. 1988;25:555-560
49. Mühlbauer B: Die therapeutische Wirksamkeit von Dopamin beim akuten Nierenversagen. Anaesthesist 1996;45:657-696
50. Murphy MB, Elliot WJ: Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit. Care Med. 1996;18:14-18
51. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM: Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth. Intens. Care 1993;21: 56-61
52. Neugebauer E, Dimmler S, Troidl H: Mediatorensysteme und Sepsis. Chirurg 1995;66:2-10
53. O'Grady JG, Tan KC, Williams R: Selection criteria and results of orthotopic liver transplantation in the UK. In: Williams R, Hughes RD (Eds.): Acute liver failure: improved understanding and better therapy. Miter Press, London 1991
54. Olson LG, Hensley MJ, Saunders NA: Ventilatory responses to hypercapnic hypoxia during dopamine infusion in humans. Am. Rev. Respir. Dis. 1982;126:783-787
55. Palmieri G, Morabito A, Lauria R, Montesarchio V, Matano E, Memoli B, Libetta C, Rea A, Merola C, Correale P, Leo L, Tagliaferri P. Bianco AR: Low-dose dopamine induces early recovery of recombinant Interleukin-2-impaired renal function. Eur. J. Cancer 1993;29:1119-1122
56. Parker S, Carlon GC, Isaacs M, Howland WS, Kahn RC: Dopamine administration in oliguria and oliguric renal failure. Crit. Care Med. 1981;9:630-632
57. Parks RW, Diamond T, McCrory DC, Johnston GW, Rowland BJ: Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br. J. Surg. 1994;81:437-439
58. Paul MD, Mazer CD, Byrick RJ, Rose DK, Goldstein MB: Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am. J. Nephrol. 1986;6:427-434
59. Pawlik W, Mailman D, Shanbour LL, Jacobson ED: Dopamine effects on the intestinal circulation. Am. Heart J. 1976;91:325-331
60. Polson RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R: The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low-dose dopamine. Anaesthesia 1987;42:15-19
61. Porter GA: Contrast-associated nephropathy. Am. J. Cardiol. 1989;64:22E
62. Prough DS: Still lethal after all these years. Crit. Care Med. 1996;24:189-190
63. Ratcliffe PJ, Endre ZH, Tange JD, Ledingham JG: Ischemic acute renal failure: why does it occur? Nephron 1989;52:1-5
64. Renotte MT, Reynaert M, Clerbaux T: Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Intens. Care Med. 1989;15: 160-165
65. Richer M, Robert S, Lebel M: Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit. Care Med. 1996;24:1150-1156
66. Robinson T, Gariballa S, Fancourt G, Potter J, Castleden M: The acute effects of a single dopamine infusion in elderly patients with congestive heart failure. Br. J. Clin. Pharmac. 1994;37:261-263
67. Rudis MI, Basha MA, Zarowitz BJ: Is it time to reposition vasopressors and inotropes in sepsis? Crit. Care Med. 1996;24: 525-537
68. Sandberg J, Tyden G, Groth CG: Low-dose dopamine infusion following cadaveric renal transplantation: no effect on the incidence of ATN. Transpl. Proc. 1992;24:357-358
69. Segal JM, Phang PT, Walley KR: Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J. Appl. Physiol. 1992;73:1159-1164
70. +-ATPase activity in rat renal cortical tubule cells. Am. J. Physiol. 1988;255:F666-673
71. Slag MF, Morley JE, Elson MK: Hypothyroxinemia in critically ill patients as a predictor of high mortality. J. Am. Med. Assoc. 1981;245:43-45
72. Swygert TH, Roberts LC, Valek TR, Brajtbord D, Brown MR, Gunning TC, Paulsen WA, Ramsay MAW: Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 1991;75:571-576
73. Talley RC, Forland M, Beller B: Reversal of acute renal failure with a combination of intravenous dopamine and diuretics. Clin. Res. 1970;518-521
74. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N. Engl. J. Med. 1996;334:1448-1460
75. Thompson BT, Cockrill BA: Renal-dose dopamine: a siren song? Lancet 1994;344:7-8
76. Thurau K, Schnermann J: Die Natriumkonzentration an den Macula-densa Zellen als regulierender Faktor für das Glomerulumfiltrat. Klin. Wschr. 1965;43:410-415
77. van den Berghe G, de Zegher F, Lauwers P: Dopamine suppresses pituitary function in infants and children. Crit. Care Med. 1994;22:1747-1753
78. van den Berghe G, de Zegher F, Lauwers P: Dopamine and the sick euthyroid syndrome in critical illness. Clin. Endocrinol. 1994;41:731-737
79. van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD: Growth hormone secretion in critical illness: effect of dopamine. J. Clin. Endocrinol. Metab. 1994;79:1141-1146
80. van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P: Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin. Endocrinol. 1995;43: 457-463
81. van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P: Thyrotropin-releasing hormone in critical illness: From a dopamine-dependent test to a strategy for increasing low serum triiodthyronine, prolactin, and growth hormone concentrations. Crit. Care Med. 1996;24:590-595
82. Vincent JL: Renal effects of dopamine: can our dream ever come true? Crit. Care Med. 1994;22:5-6
83. Wartofski L, Burmann KD: Alterations in thyroid function in patients with systemic illness: The "euthyroid sick syndrome". Endocrin. Rev. 1982;3:164-167
84. Weisberg LS, Kurnik PB, Kurnik BR: Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren. Fail. 1993;15:61-68
85. Wells CL: Bacterial translocation: cause or effect of multiple organ failure? In Vincent JL (ed.):Yearbook of intensive care and emergency medicine. Springer, Berlin, 1996
86. Welsh MJ, Heistad DD, Abboud FM: Depression of ventilation by dopamine in man. J. Clin. Invest. 1978;61:708-713